Guardant Health: Steve Krognes

Guardant Health has appointed Steve Krognes to its board of directors. He currently serves as a director at Denali Therapeutics, Gritstone Bio, and RLS Global. He previously served on the board of Corvus Pharmaceuticals.

Before joining Guardant's board, Krognes was the CFO of Denali Therapeutics. Prior to that, he served in a variety of roles at multinational corporations, including CFO at Genentech. He chaired the Genentech Access to Care Foundation and represented Genentech on the board and executive committee of the California Life Science Association. Before that, he worked as global head of mergers and acquisitions at Roche, as an investment banker at Goldman Sachs, as a management consultant at McKinsey & Company, and as a venture capitalist in Scandinavia. Krognes holds an MBA from Harvard Business School and a BS in economics from the Wharton School of the University of Pennsylvania.